GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Shanghai Pharmaceuticals Holding Co Ltd (SHSE:601607) » Definitions » EV-to-FCF

Shanghai Pharmaceuticals Holding Co (SHSE:601607) EV-to-FCF : 25.21 (As of Dec. 13, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Shanghai Pharmaceuticals Holding Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Shanghai Pharmaceuticals Holding Co's Enterprise Value is ¥80,443 Mil. Shanghai Pharmaceuticals Holding Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was ¥3,191 Mil. Therefore, Shanghai Pharmaceuticals Holding Co's EV-to-FCF for today is 25.21.

The historical rank and industry rank for Shanghai Pharmaceuticals Holding Co's EV-to-FCF or its related term are showing as below:

SHSE:601607' s EV-to-FCF Range Over the Past 10 Years
Min: -1862.55   Med: 34.11   Max: 23987.84
Current: 24.94

During the past 13 years, the highest EV-to-FCF of Shanghai Pharmaceuticals Holding Co was 23987.84. The lowest was -1862.55. And the median was 34.11.

SHSE:601607's EV-to-FCF is ranked worse than
62.03% of 79 companies
in the Medical Distribution industry
Industry Median: 17.51 vs SHSE:601607: 24.94

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-13), Shanghai Pharmaceuticals Holding Co's stock price is ¥21.74. Shanghai Pharmaceuticals Holding Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥1.080. Therefore, Shanghai Pharmaceuticals Holding Co's PE Ratio (TTM) for today is 20.13.


Shanghai Pharmaceuticals Holding Co EV-to-FCF Historical Data

The historical data trend for Shanghai Pharmaceuticals Holding Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pharmaceuticals Holding Co EV-to-FCF Chart

Shanghai Pharmaceuticals Holding Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.37 19.15 80.08 38.09 34.92

Shanghai Pharmaceuticals Holding Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.23 34.92 -112.72 72.11 30.81

Competitive Comparison of Shanghai Pharmaceuticals Holding Co's EV-to-FCF

For the Medical Distribution subindustry, Shanghai Pharmaceuticals Holding Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Pharmaceuticals Holding Co's EV-to-FCF Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Shanghai Pharmaceuticals Holding Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Shanghai Pharmaceuticals Holding Co's EV-to-FCF falls into.



Shanghai Pharmaceuticals Holding Co EV-to-FCF Calculation

Shanghai Pharmaceuticals Holding Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=80442.575/3190.734
=25.21

Shanghai Pharmaceuticals Holding Co's current Enterprise Value is ¥80,443 Mil.
Shanghai Pharmaceuticals Holding Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥3,191 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Pharmaceuticals Holding Co  (SHSE:601607) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Shanghai Pharmaceuticals Holding Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=21.74/1.080
=20.13

Shanghai Pharmaceuticals Holding Co's share price for today is ¥21.74.
Shanghai Pharmaceuticals Holding Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.080.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Shanghai Pharmaceuticals Holding Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Shanghai Pharmaceuticals Holding Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Pharmaceuticals Holding Co Business Description

Traded in Other Exchanges
Address
No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Shanghai Pharmaceuticals is the second-largest medical distributor in China by revenue. It is vertically integrated and provides healthcare services in research and development, manufacturing, distribution, and retail. As of 2023, medical distribution is the largest segment, accounting for 89.8% of total revenue. It also has coverage of 31 provinces and cities nationwide.
Executives
Ren Jian senior management
Liu Yan Jun senior management
Hu Feng Xiang Director
Zuo Min Director
Guo Jun Yu senior management
Han Min senior management
Lou Ding Bo Director
Chen Xin Supervisors
Shu Chang senior management
Li Yong Zhong senior management
Jiang Yuan Ying senior management
Xu Guo Xiong Director
Shen Bo senior management
Ge Jian Qiu senior management

Shanghai Pharmaceuticals Holding Co Headlines

No Headlines